Cracking the Code: Understanding Congenital Myasthenic Syndrome 21 Through Genetic Testing
Explore the role of genetic testing in diagnosing CMS21, RAPSN gene mutations, and tailored treatments. Discover insights from Iranian patient studies.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Congenitally Corrected Transposition of the Great Arteries: Genetic Testing's Crucial Role
Explore the impact of genetic testing in diagnosing Congenitally Corrected Transposition of the Great Arteries (CCTGA), personalized treatments, and patient outcomes.
Deciphering Developmental and Epileptic Encephalopathy, 40: Genetic Testing as a Guiding Light
Unlock the potential of genetic testing in diagnosing and managing Developmental and Epileptic Encephalopathy, 40. Discover personalized treatment paths today.
Decoding Developmental and Epileptic Encephalopathy, 41: The Role of Genetic Testing
Unlock the potential of genetic testing in diagnosing and managing DEE41. Discover how personalized care improves outcomes and offers family planning insights.
Decoding Developmental and Epileptic Encephalopathy, 42: The Role of Genetic Testing
Explore how genetic testing aids in diagnosing DEE42, guiding treatment, and informing family planning, while overcoming challenges in variant interpretation and accessibility.
Decoding Developmental and Epileptic Encephalopathy, 43: The Role of Genetic Testing
Explore how genetic testing transforms diagnosis and treatment of Developmental and Epileptic Encephalopathy, 43, improving patient outcomes and guiding family planning.
Decoding Developmental and Epileptic Encephalopathy, 44: The Role of Genetic Testing
Explore how genetic testing revolutionizes the diagnosis and treatment of DEE44, a complex disorder caused by UBA5 gene mutations, enhancing personalized care.
Deciphering Developmental and Epileptic Encephalopathy, 45: The Role of Genetic Testing
Explore how genetic testing aids in diagnosing DEE45, a severe neurological disorder, by identifying gene variants like GABRB1, enabling personalized treatment plans.